#Hypoparathyroidism

[the-autistic-system]

Y'all tell me why my body just has to rack up every rare disease ever (let me be dramatic), Recently my doc did some labs and my calcium came back low; did more labs to find out why, and the verdict? I have hypoparathyroidism.

Now hypothyroidism runs in my family, so idk if it could be hereditary, but it could be from damage done to my parathyroids– not from surgery, but from when I had covid two (2) years ago (looked it up if that could happen and there have been cases reported of hypoparathyroidism after covid so), that's when my symptoms started, but I had bigger things going on so we hadn't caught it until now. Treatment is simple though, just take the right amount of supplements everyday.

💕 love being chronically ill lmao

[doomhole]

cw: personal, medical

So a while ago, I started having what is commonly known as "formication", the hallucinatory sensation of having something on your skin, in my case specifically around my mouth. And yeah, I'm a mentally ill trainwreck, but I know my own hallucinatory symptoms, you know? I'm not a skin picker nor have I ever had tactile hallucinations, so this stood out.

Consulting the well-known Doctor Google gave me, besides the usual options (anxiety, panic attack, psychosis), the possibility of a parathyroid dysfunction. Which is something people take supplements for, specifically calcium, vitamin D and magnesium.

So... seeing as that's pretty much harmless to try even if it wouldn't help, I gave it a shot.

Literally three days later, formication gone. Whoo! Parathyroid problem or placebo effect? Who knows, I didn't care, my face stopped feeling weird!

That was like, over a month ago. Now last week, I ran out of those supplements, and being my adhd self, I totally forgot to order new ones, having already mostly forgotten why I took them to begin with.

Guess what it bugging me today.

Yep, it's my old friend, formication around my mouth.

...

I am wondering if I should see an actual doctor about this. Given that this may actually be a real physical issue and not just me being busted in the head as usual.

However, the temptation to just take the supplements again and be done with it is very real. Why would I even have a parathyroid issue? I haven't had neck surgery nor do I have autoimmune disease or a family history of hypoparathyroidism, so my only possible avenues are chronic magnesium deficiency from malnutrition or an undiagnosed endocrine issue. AKA chances are the doctor will just send me home with an eyeroll and a script for antipsychotics.

Even though this could possibly be linked to my hair loss, shit skin and nails, digestive issues, and the inexplicable severe hypertension I already take 3 prescription drugs for.

Anyway, I ordered new pills.

[marccurelab]

Calvit CT Tablet | Buy strip of 10 tablets at best price in India | Marccure

Calvit CT plays a vital role in bone growth and development.  It prevents a low level of calcium in the body and makes your body relax which is adequate for growth & development. It contains calcium citrate which is used to treat conditions caused by low calcium levels such as bone loss (osteoporosis), weak bones (osteomalacia/rickets), decreased activity of the parathyroid gland (hypoparathyroidism), and certain muscle diseases (latent tetany).

The zinc and magnesium compound makes the immune system strong , gives  better metabolism and prevents inflammatory disease.

Use of calvit CT:

It is used to maintain bone density.

Also used for calcium deficiency in the body.

Prevent osteoporosis.

Makes bones strong.

Increased the activity of thyroid gland.

[skylerlovesyou]

i’m vitaminmaxxing

[lady0mandy]

I love how my parathyroids literally aren't working and my insurance still refuses to cover either of the calcium pills that I need to take several times a day

[diet2all]

היפופראתירואידיזם, היפופאראתירואידיזם, היפרפאראתירואידיזם תזונה,  תת פעילות של בלוטת יותרת התריס המכונה: היפופאראתירואידיזם או תת פעילות של בלוטת הפראתירויד (Hypoparathyroidism). המצב נוצר מירידה או חוסר פעילות של הורמון הפראתירואיד (PTH) על רקמות המטרה, אשר באופן תקין נתונות להשפעתו, לצורך ויסות משק המינרלים (סידן, זרחן ומגנזיום) בגוף. ההורמון PTH הידוע גם בשם parathormone, נוצר ע"י בלוטות הפאראתירואיד. אלו הן ארבע בלוטות בגודל אפונה הממוקמות בצוואר. ה-PTH שולט ברמת הסידן בדם. הסידן הוא מינרל ששומר על העצמות והשיניים בריאות וחזקות. וחיוני לתפקוד תקין של העצבים, השרירים ושריר הלב. #היפופראתירואידיזם #פאראתירואיד #קוביעזרא #תזונה https://youtu.be/cnJxB5ZhvhQ

[ray-beck]

medical fact of the day:

pseudopseudohypoparathyroidism is a real condition, and it's your dad's fault

[black-bird-red-belly]

Bosh Ti "Antilles" He wraps his lekku around his neck (and under the head-tail in the back) to hide his voice modulator in his throat! He suffered a wound to his neck when his sith master tried to execute him, but he managed to pull through with injury to his thyroid/parathyroid glands (and his windpipe/larynx). He has hypoparathyroidism and requires regular infusions to keep in good shape :)

[thatwritingho]

Hey, guys. Just as a small update:

My life has been... not great lately, to put it mildly. In the last 6 months, I have experienced:

The death of my hamster

My father's s*icide

The death anniversary of my dog

The death of my favorite uncle

My cat having an unexpected seuzure, nearly dying in my arms, staying overnight in the emergency vet multiple nught, then fibally being diagnosed with feline hypoparathyroidism, which is very rare. His medicine is $130/month.

And, as if all of that wasn't enough... my husband walked out on me unexpectedly last weekend. Very brief details on this below the cut.

I won't go into details, but my husband and I had been together since high school, dating for twelve years and married five. He thought about it for two weeks, talked to me about the issues he was dissatisfied with(which he had not communicated before) for about one week, and then left.

I am physically disabled by a chronic pain condition.

He makes 3x more income than I do.

He is taking half of our animals with him.

So... that's why I have been absent for months.

Any kind words or shows of support are appreciated.❤️

[teachingrounds]

Classic findings of HYPOparathyroidism include...

- hypocalcemia +/- hypomagnesemia

- hyperphosphatemia

- DECREASED serum PTH

- fatigue/mood swings

Pro-tip: After total thyroidectomy, the risk of permanent hypoparathyroidism is 1-3%. All other causes are even rarer.

Image: Wikimedia

[kathansky]

Hormone Replacement Therapy Market Global Size, Share, Growth, Industry Trends | 2024-2031

Leading market research firm SkyQuest Technology Group recently released a study titled 'Hormone Replacement Therapy Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Hormone Replacement Therapy report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Hormone Replacement Therapy Market extensively demonstrates existing and upcoming opportunities, profitability, revenue growth rates, pricing, and scenarios for recent industry analysis.

The research analysis on the global Hormone Replacement Therapy Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Hormone Replacement Therapy Market circumstances in the forecast period between 2024 and 2031. The global Hormone Replacement Therapy Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements. Market Growth The Hormone Replacement Therapy Market has experienced robust growth over the past decade and is projected to continue expanding. Hormone Replacement Therapy (HRT) Market size was valued at USD 24.97 billion in 2022 and is poised to grow from USD 26.87 billion in 2023 to USD 49.25 billion by 2031, growing at a CAGR of 7.83% in the forecast period (2024-2031). This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure.

Chance to get a free sample @ https://www.skyquestt.com/sample-request/hormone-replacement-therapy-market 

Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR): The Hormone Replacement Therapy Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs.

Product

Estrogen & Progesterone Replacement Therapy, HGH replacement therapy, Thyroid hormone replacement therapy, Testosterone Replacement Therapy, Parathyroid Hormone Replacement

Route Of Administration

Oral, Parenteral, Transdermal, Others

Disease Type

Menopause, Hypothyroidism, Male hypogonadism, Growth hormone deficiency, Hypoparathyroidism

Regional Analysis: On the basis of region, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The Hormone Replacement Therapy Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Get your customized report @ https://www.skyquestt.com/speak-with-analyst/hormone-replacement-therapy-market 

Following are the players analyzed in the report:

Eli Lilly and Company (US)

Bayer AG (Germany)

Pfizer Inc. (US)

Viatris, Inc. (US)

Novo Nordisk A/S

Novartis International AG

Merck & Co. Inc.

Mylan N.V.

TherapeuticsMD Inc.

Abbott Laboratories

Allergan plc

Teva Pharmaceutical Industries Ltd.

Amgen Inc.

AbbVie Inc.

Ferring Pharmaceuticals

GlaxoSmithKline plc

Johnson & Johnson

Ipsen S.A.

Sanofi S.A.

Regional Analysis 1. North America: - The United States and Canada dominate the North American Hormone Replacement Therapy Market. The U.S. is the largest market globally, driven by advanced global infrastructure, high R&D investments, and significant Hormone Replacement Therapy consumption. 2. Europe: - Europe is a significant player, with major Hormone Replacement Therapy Markets in Germany, France, and the United Kingdom. The region benefits from strong regulatory frameworks, high industry standards, and a robust R&D sector. 3. Asia-Pacific: - This region is experiencing rapid growth, with countries like China and India leading the charge. Factors such as increasing industry access, growing middle-class populations, and expanding Hormone Replacement Therapy manufacturing capabilities contribute to this growth. 4. Latin America: - Brazil and Mexico are key markets in Latin America. Growth in this region is driven by rising industry needs, increasing investments in industry infrastructure, and a growing demand for affordable medications. 5. Middle East and Africa: - The Hormone Replacement Therapy Market in this region is expanding due to rising market spending, increased prevalence of diseases, and improvements in Market infrastructure, although the market is relatively smaller compared to other regions. Future Outlook The Hormone Replacement Therapy Market is poised for continued growth driven by technological advancements, expanding global market access, and increasing global industry needs. As the industry adapts to evolving challenges and seizes emerging opportunities, it is likely to see ongoing innovation and expansion, contributing significantly to global health and economic development.

Buy your full report: https://www.skyquestt.com/buy-now/hormone-replacement-therapy-market 

[hopetribune]

Hypoparathyroidism Market Growth Anticipated by 2034 | Companies includes Takeda, Ascendis Pharma, EnteraBio, Bridgebio, Calcilytix Therapeutics

http://dlvr.it/TDBmcP

[newsheadlinesnow]

Hypoparathyroidism Market Growth Anticipated by 2034 | Companies includes Takeda, Ascendis Pharma, EnteraBio, Bridgebio, Calcilytix Therapeutics

http://dlvr.it/TDBmQp

[conversationpoint]

Hypoparathyroidism Market Growth Anticipated by 2034 | Companies includes Takeda, Ascendis Pharma, EnteraBio, Bridgebio, Calcilytix Therapeutics

http://dlvr.it/TDBm9Y

[amcrasto]

Palopegteriparatide

Palopegteriparatide Yorvipath , FDA 2024, 8/9/2024, To treat hypoparathyroidism G2N64C3385 2222514-07-8 Palopegteriparatide UNII-G2N64C3385 ACP-014 Mpeg 40000-teriparatide Palopegteriparatide [INN] Transcon parathyroid hormone (1-34) Transcon pth (1-34) Palopegteriparatide [USAN] TransCon PTH WHO 11060 PalopegteriparatidePalopegteriparatide is a human parathyroid hormone analogue…